Skip to main content
. 2022 Jan 17;12:786334. doi: 10.3389/fphar.2021.786334

FIGURE 3.

FIGURE 3

The comparison of CR and TR rates between high titer group and non-high titer group at different time points in different patients. CR (A1) and TR (A2) in overall cohort, CR (B1) and TR (B2) in CTX group, CR (C1) and TR (C2) in TAC group. CR: complete remission; TR: total remission; CTX: cyclophosphamide; TAC: tacrolimus. *p < 0.05, **p < 0.01, ***p < 0.001.